StratiCELL Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 7
Employees
  • Latest Deal Type
  • M&A

StratiCELL General Information

Description

Developer of in vitro regulatory toxicology and test methods. The company assists cosmetic, pharmaceutical, chemical and food industries in evaluating the safety and efficacy of their compounds by means of in vitro models and methods.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Science Park Crealys
  • Rue Jean Sonet 10
  • 5032 Isnes
  • Belgium
+32 081 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StratiCELL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 07-Jan-2016 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view StratiCELL’s complete valuation and funding history, request access »

StratiCELL Executive Team (2)

Name Title Board Seat Contact Info
Michel Salmon Ph.D Chief Executive Officer & General and Scientific Manager
Aline Chrétien Study Director
To view StratiCELL’s complete executive team members history, request access »

StratiCELL Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StratiCELL Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Namur Invest Venture Capital Minority 000 0000 000000 0
To view StratiCELL’s complete investors history, request access »